nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Edema of lower extremities—Docetaxel—head and neck cancer	0.0656	0.0656	CcSEcCtD
Solifenacin—Ileus—Vinblastine—head and neck cancer	0.0393	0.0393	CcSEcCtD
Solifenacin—Foetor hepaticus—Docetaxel—head and neck cancer	0.0232	0.0232	CcSEcCtD
Solifenacin—Intestinal obstruction—Docetaxel—head and neck cancer	0.0193	0.0193	CcSEcCtD
Solifenacin—Liver disorder—Docetaxel—head and neck cancer	0.0193	0.0193	CcSEcCtD
Solifenacin—Ileus—Docetaxel—head and neck cancer	0.0186	0.0186	CcSEcCtD
Solifenacin—Depression—Vinblastine—head and neck cancer	0.0155	0.0155	CcSEcCtD
Solifenacin—Dysuria—Hydroxyurea—head and neck cancer	0.0149	0.0149	CcSEcCtD
Solifenacin—Drug interaction—Docetaxel—head and neck cancer	0.0142	0.0142	CcSEcCtD
Solifenacin—Infestation NOS—Hydroxyurea—head and neck cancer	0.0142	0.0142	CcSEcCtD
Solifenacin—Infestation—Hydroxyurea—head and neck cancer	0.0142	0.0142	CcSEcCtD
Solifenacin—Pharyngitis—Vinblastine—head and neck cancer	0.0138	0.0138	CcSEcCtD
Solifenacin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0134	0.0134	CcSEcCtD
Solifenacin—Hepatocellular injury—Docetaxel—head and neck cancer	0.0132	0.0132	CcSEcCtD
Solifenacin—Hallucination—Hydroxyurea—head and neck cancer	0.0127	0.0127	CcSEcCtD
Solifenacin—Dry skin—Fluorouracil—head and neck cancer	0.0121	0.0121	CcSEcCtD
Solifenacin—Muscular weakness—Fluorouracil—head and neck cancer	0.0117	0.0117	CcSEcCtD
Solifenacin—Angiopathy—Hydroxyurea—head and neck cancer	0.0115	0.0115	CcSEcCtD
Solifenacin—Hypertension—Vinblastine—head and neck cancer	0.0105	0.0105	CcSEcCtD
Solifenacin—Infestation NOS—Fluorouracil—head and neck cancer	0.0102	0.0102	CcSEcCtD
Solifenacin—Infestation—Fluorouracil—head and neck cancer	0.0102	0.0102	CcSEcCtD
Solifenacin—Atrial fibrillation—Docetaxel—head and neck cancer	0.0101	0.0101	CcSEcCtD
Solifenacin—Renal impairment—Docetaxel—head and neck cancer	0.01	0.01	CcSEcCtD
Solifenacin—Urinary tract infection—Fluorouracil—head and neck cancer	0.00992	0.00992	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00936	0.00936	CcSEcCtD
Solifenacin—Pharyngitis—Fluorouracil—head and neck cancer	0.00909	0.00909	CcSEcCtD
Solifenacin—Infection—Hydroxyurea—head and neck cancer	0.00898	0.00898	CcSEcCtD
Solifenacin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00887	0.00887	CcSEcCtD
Solifenacin—Liver function test abnormal—Docetaxel—head and neck cancer	0.00882	0.00882	CcSEcCtD
Solifenacin—Skin disorder—Hydroxyurea—head and neck cancer	0.00878	0.00878	CcSEcCtD
Solifenacin—Dry skin—Docetaxel—head and neck cancer	0.00876	0.00876	CcSEcCtD
Solifenacin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00873	0.00873	CcSEcCtD
Solifenacin—Decreased appetite—Vinblastine—head and neck cancer	0.00862	0.00862	CcSEcCtD
Solifenacin—Constipation—Vinblastine—head and neck cancer	0.00848	0.00848	CcSEcCtD
Solifenacin—Feeling abnormal—Vinblastine—head and neck cancer	0.00817	0.00817	CcSEcCtD
Solifenacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00811	0.00811	CcSEcCtD
Solifenacin—Somnolence—Hydroxyurea—head and neck cancer	0.00804	0.00804	CcSEcCtD
Solifenacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00796	0.00796	CcSEcCtD
Solifenacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00786	0.00786	CcSEcCtD
Solifenacin—Abdominal pain—Vinblastine—head and neck cancer	0.00784	0.00784	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0078	0.0078	CcSEcCtD
Solifenacin—Fatigue—Hydroxyurea—head and neck cancer	0.00779	0.00779	CcSEcCtD
Solifenacin—Constipation—Hydroxyurea—head and neck cancer	0.00773	0.00773	CcSEcCtD
Solifenacin—Vision blurred—Fluorouracil—head and neck cancer	0.00751	0.00751	CcSEcCtD
Solifenacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00745	0.00745	CcSEcCtD
Solifenacin—Infestation—Docetaxel—head and neck cancer	0.00736	0.00736	CcSEcCtD
Solifenacin—Infestation NOS—Docetaxel—head and neck cancer	0.00736	0.00736	CcSEcCtD
Solifenacin—Hypersensitivity—Vinblastine—head and neck cancer	0.0073	0.0073	CcSEcCtD
Solifenacin—Renal failure—Docetaxel—head and neck cancer	0.00724	0.00724	CcSEcCtD
Solifenacin—Asthenia—Vinblastine—head and neck cancer	0.00711	0.00711	CcSEcCtD
Solifenacin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00696	0.00696	CcSEcCtD
Solifenacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00666	0.00666	CcSEcCtD
Solifenacin—Confusional state—Fluorouracil—head and neck cancer	0.00656	0.00656	CcSEcCtD
Solifenacin—Pharyngitis—Docetaxel—head and neck cancer	0.00656	0.00656	CcSEcCtD
Solifenacin—Dizziness—Vinblastine—head and neck cancer	0.00655	0.00655	CcSEcCtD
Solifenacin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00653	0.00653	CcSEcCtD
Solifenacin—Oedema peripheral—Docetaxel—head and neck cancer	0.00651	0.00651	CcSEcCtD
Solifenacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00651	0.00651	CcSEcCtD
Solifenacin—Connective tissue disorder—Docetaxel—head and neck cancer	0.0065	0.0065	CcSEcCtD
Solifenacin—Asthenia—Hydroxyurea—head and neck cancer	0.00649	0.00649	CcSEcCtD
Solifenacin—Urethral disorder—Docetaxel—head and neck cancer	0.00648	0.00648	CcSEcCtD
Solifenacin—Infection—Fluorouracil—head and neck cancer	0.00646	0.00646	CcSEcCtD
Solifenacin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00638	0.00638	CcSEcCtD
Solifenacin—Tachycardia—Fluorouracil—head and neck cancer	0.00635	0.00635	CcSEcCtD
Solifenacin—Vomiting—Vinblastine—head and neck cancer	0.0063	0.0063	CcSEcCtD
Solifenacin—Erythema multiforme—Docetaxel—head and neck cancer	0.00625	0.00625	CcSEcCtD
Solifenacin—Headache—Vinblastine—head and neck cancer	0.00621	0.00621	CcSEcCtD
Solifenacin—Eye disorder—Docetaxel—head and neck cancer	0.00618	0.00618	CcSEcCtD
Solifenacin—Cardiac disorder—Docetaxel—head and neck cancer	0.00613	0.00613	CcSEcCtD
Solifenacin—Angiopathy—Docetaxel—head and neck cancer	0.006	0.006	CcSEcCtD
Solifenacin—Dizziness—Hydroxyurea—head and neck cancer	0.00598	0.00598	CcSEcCtD
Solifenacin—Immune system disorder—Docetaxel—head and neck cancer	0.00597	0.00597	CcSEcCtD
Solifenacin—Mediastinal disorder—Docetaxel—head and neck cancer	0.00596	0.00596	CcSEcCtD
Solifenacin—Nausea—Vinblastine—head and neck cancer	0.00589	0.00589	CcSEcCtD
Solifenacin—Mental disorder—Docetaxel—head and neck cancer	0.00579	0.00579	CcSEcCtD
Solifenacin—Somnolence—Fluorouracil—head and neck cancer	0.00578	0.00578	CcSEcCtD
Solifenacin—Malnutrition—Docetaxel—head and neck cancer	0.00575	0.00575	CcSEcCtD
Solifenacin—Vomiting—Hydroxyurea—head and neck cancer	0.00575	0.00575	CcSEcCtD
Solifenacin—Dyspepsia—Fluorouracil—head and neck cancer	0.00573	0.00573	CcSEcCtD
Solifenacin—Rash—Hydroxyurea—head and neck cancer	0.0057	0.0057	CcSEcCtD
Solifenacin—Dermatitis—Hydroxyurea—head and neck cancer	0.00569	0.00569	CcSEcCtD
Solifenacin—Headache—Hydroxyurea—head and neck cancer	0.00566	0.00566	CcSEcCtD
Solifenacin—Decreased appetite—Fluorouracil—head and neck cancer	0.00566	0.00566	CcSEcCtD
Solifenacin—Dysgeusia—Docetaxel—head and neck cancer	0.00564	0.00564	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00562	0.00562	CcSEcCtD
Solifenacin—Nausea—Hydroxyurea—head and neck cancer	0.00537	0.00537	CcSEcCtD
Solifenacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00536	0.00536	CcSEcCtD
Solifenacin—Urticaria—Fluorouracil—head and neck cancer	0.00517	0.00517	CcSEcCtD
Solifenacin—Palpitations—Docetaxel—head and neck cancer	0.00509	0.00509	CcSEcCtD
Solifenacin—Cough—Docetaxel—head and neck cancer	0.00502	0.00502	CcSEcCtD
Solifenacin—Hypertension—Docetaxel—head and neck cancer	0.00497	0.00497	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00487	0.00487	CcSEcCtD
Solifenacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00479	0.00479	CcSEcCtD
Solifenacin—Dry mouth—Docetaxel—head and neck cancer	0.00479	0.00479	CcSEcCtD
Solifenacin—Confusional state—Docetaxel—head and neck cancer	0.00474	0.00474	CcSEcCtD
Solifenacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.0047	0.0047	CcSEcCtD
Solifenacin—Infection—Docetaxel—head and neck cancer	0.00467	0.00467	CcSEcCtD
Solifenacin—Nervous system disorder—Docetaxel—head and neck cancer	0.00461	0.00461	CcSEcCtD
Solifenacin—Pruritus—Fluorouracil—head and neck cancer	0.0046	0.0046	CcSEcCtD
Solifenacin—Tachycardia—Docetaxel—head and neck cancer	0.00458	0.00458	CcSEcCtD
Solifenacin—Skin disorder—Docetaxel—head and neck cancer	0.00456	0.00456	CcSEcCtD
Solifenacin—Dizziness—Fluorouracil—head and neck cancer	0.0043	0.0043	CcSEcCtD
Solifenacin—Somnolence—Docetaxel—head and neck cancer	0.00418	0.00418	CcSEcCtD
Solifenacin—Vomiting—Fluorouracil—head and neck cancer	0.00414	0.00414	CcSEcCtD
Solifenacin—Dyspepsia—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Solifenacin—Rash—Fluorouracil—head and neck cancer	0.0041	0.0041	CcSEcCtD
Solifenacin—Dermatitis—Fluorouracil—head and neck cancer	0.0041	0.0041	CcSEcCtD
Solifenacin—Decreased appetite—Docetaxel—head and neck cancer	0.00408	0.00408	CcSEcCtD
Solifenacin—Headache—Fluorouracil—head and neck cancer	0.00408	0.00408	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00405	0.00405	CcSEcCtD
Solifenacin—Fatigue—Docetaxel—head and neck cancer	0.00405	0.00405	CcSEcCtD
Solifenacin—Constipation—Docetaxel—head and neck cancer	0.00402	0.00402	CcSEcCtD
Solifenacin—Feeling abnormal—Docetaxel—head and neck cancer	0.00387	0.00387	CcSEcCtD
Solifenacin—Nausea—Fluorouracil—head and neck cancer	0.00386	0.00386	CcSEcCtD
Solifenacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00384	0.00384	CcSEcCtD
Solifenacin—Abdominal pain—Docetaxel—head and neck cancer	0.00371	0.00371	CcSEcCtD
Solifenacin—Hypersensitivity—Docetaxel—head and neck cancer	0.00346	0.00346	CcSEcCtD
Solifenacin—Asthenia—Docetaxel—head and neck cancer	0.00337	0.00337	CcSEcCtD
Solifenacin—Pruritus—Docetaxel—head and neck cancer	0.00332	0.00332	CcSEcCtD
Solifenacin—Dizziness—Docetaxel—head and neck cancer	0.00311	0.00311	CcSEcCtD
Solifenacin—Vomiting—Docetaxel—head and neck cancer	0.00299	0.00299	CcSEcCtD
Solifenacin—Rash—Docetaxel—head and neck cancer	0.00296	0.00296	CcSEcCtD
Solifenacin—Dermatitis—Docetaxel—head and neck cancer	0.00296	0.00296	CcSEcCtD
Solifenacin—Headache—Docetaxel—head and neck cancer	0.00294	0.00294	CcSEcCtD
Solifenacin—Nausea—Docetaxel—head and neck cancer	0.00279	0.00279	CcSEcCtD
